The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Market Size Of The Endovascular Stent Grafts Market In 2026, And How Will Its Value Evolve By 2030?
The endovascular stent grafts market has experienced substantial growth in recent years. It is projected to increase from $1.45 billion in 2025 to $1.99 billion in 2026, at a compound annual growth rate (CAGR) of 37.9%. This historical growth can be attributed to several factors, including reliance on conventional open surgical procedures, limited availability of advanced stent graft materials, the growing prevalence of vascular diseases, early adoption of coronary and peripheral grafts, and increasing awareness of aortic aneurysm treatments.
The endovascular stent grafts market is projected to experience rapid expansion over the coming years. This market is anticipated to reach $7.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 37.5%. This growth during the projected timeframe stems from advancements in endovascular stent graft technology, an increase in minimally invasive surgical procedures, a rise in aortic aneurysm and dissection occurrences, greater uptake of hybrid vascular grafts, and the expansion of cardiovascular healthcare facilities. Key trends expected throughout the forecast period encompass a growing preference for minimally invasive endovascular interventions, an escalating need for tailored stent grafts, innovations in hybrid and biologic graft substances, an increase in thoracic and abdominal aortic repair operations, and a heightened emphasis on patient welfare and adherence to regulations.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20549&type=smp
What Primary Drivers Are Shaping The Endovascular Stent Grafts Market?
The expanding endovascular stent graft market is anticipated to grow due to the increasing prevalence of cardiovascular diseases (CVD), which are conditions affecting the heart or blood vessels. This rise in CVD cases is attributed to a combination of lifestyle choices, existing medical conditions, genetic factors, and environmental influences. Endovascular stent grafts present a valuable solution for managing cardiovascular diseases by minimizing invasiveness and improving patient results. These grafts reinforce weakened vessel walls, thereby preventing ruptures and mitigating the risk of severe complications. For example, in October 2025, the Australian Institute Of Health And Welfare, an Australia-based government agency, indicated that an estimated 57,100 adults aged 25 and above suffered acute coronary events in 2023, averaging roughly 156 incidents daily. Thus, the escalating incidence of cardiovascular diseases is a primary driver for the growth of the endovascular stent graft market.
What Are The Key Segment Divisions In The Endovascular Stent Grafts Market Segment Structure?
The endovascular stent grafts market covered in this report is segmented –
1) By Product: Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts For Aorta Disease, Peripheral Vascular Grafts
2) By Raw Material: Synthetic Vascular Grafts, Biological Vascular Grafts, Hybrid Vascular Grafts
3) By Application: Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease
Subsegments:
1) By Hemodialysis Access Grafts: Arteriovenous (AV) Fistula Grafts, Synthetic Hemodialysis Access Grafts, Bioengineered Hemodialysis Access Grafts, Coated Hemodialysis Grafts, Endovascular Hemodialysis Grafts
2) By Endovascular Stent Grafts: Aneurysm Stent Grafts, Stent Grafts For Aortic Dissection, Thoracic Endovascular Stent Grafts, Abdominal Endovascular Stent Grafts, Biliary Endovascular Stent Grafts
3) By Coronary Artery By-Pass Grafts: Saphenous Vein Grafts (SVG), Arterial Coronary Bypass Grafts, Endovascular Coronary Artery Bypass Grafts (CABG), Synthetic Coronary Bypass Grafts
4) By Vascular Grafts For Aorta Disease: Endovascular Aortic Stent Grafts, Aortic Aneurysm Grafts, Aortic Bypass Grafts, Thoracoabdominal Aortic Stent Grafts, Aortic Dissection Stent Grafts
5) By Peripheral Vascular Grafts: Carotid Artery Stent Grafts, Femoral Artery Stent Grafts, Popliteal Artery Stent Grafts, Iliac Artery Stent Grafts, Peripheral Endovascular Stent Grafts
What Trends Are Affecting The Growth Of The Endovascular Stent Grafts Market?
Leading companies in the endovascular stent grafts market are concentrating on developing innovative products like thoracic aortic stent-grafts to enhance the precision and effectiveness of treating thoracic aortic aneurysms and dissections, thereby improving patient outcomes and addressing complex anatomical challenges through advanced technology and design improvements. A thoracic aortic stent graft is a specialized medical device employed in endovascular surgery to manage diseases and conditions of the thoracic aorta, the section of the aorta located in the chest, offering a combination of safety, effectiveness, and convenience for tackling thoracic aortic diseases. For instance, in February 2024, Endovastec, a China-based medical device company, introduced the Multi-Branch Thoracic Aortic Stent-Graft System (Hector) and completed its initial clinical application in Switzerland. The Hector system marks a significant advancement in endovascular stent graft technology. Its multi-branch design facilitates the treatment of complex thoracic aortic conditions by accommodating and preserving essential branches of the aorta, such as the arteries that supply vital organs.
Which Organizations Are Engaged In The Endovascular Stent Grafts Market?
Major companies operating in the endovascular stent grafts market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates Inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc., Endovastec Medical Technology Co Ltd., Jotec GmbH, Bentley InnoMed GmbH, Bolton Medical Inc., Alvimedica, Endospan Ltd., Vivasure Medical Ltd.
Get The Full Endovascular Stent Grafts Market Report:
https://www.thebusinessresearchcompany.com/report/endovascular-stent-grafts-global-market-report
Which Region Has The Greatest Market Share In The Endovascular Stent Grafts Market?
North America was the largest region in the endovascular stent grafts market in 2025. The regions covered in the endovascular stent grafts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Endovascular Stent Grafts Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=20549&type=smp
Browse Through More Reports Similar to the Global Endovascular Stent Grafts Market 2026, By The Business Research Company
Embolization Coils Market Report 2026
https://www.thebusinessresearchcompany.com/report/embolization-coils-global-market-report
Aortic Aneurysm Market Report 2026
https://www.thebusinessresearchcompany.com/report/aortic-aneurysm-global-market-report
Aortic Aneurysm Market Report 2026
https://www.thebusinessresearchcompany.com/report/aortic-aneurysm-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model